Jazz Pharmaceuticals
(NASDAQ:JAZZ)
$156.54
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$156.54
PreMarket: 4:32PM EDT
Day Range- - -52 Wk Range119.64 - 169.98Open / Close- / -Float / Outstanding55M / 63M
Vol / Avg.- / 536.8KMkt Cap9.9BP/E-50d Avg. Price140.7
Div / Yield-Payout Ratio-Total Float55MEPS-0.31

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range119.64 - 169.98Open / Close- / -Float / Outstanding55M / 63M
Vol / Avg.- / 536.8KMkt Cap9.9BP/E-50d Avg. Price140.7
Div / Yield-Payout Ratio-Total Float55MEPS-0.31
Seeking Alpha - Nov 24, 2022, 2:40AM
Seeking Alpha - Nov 8, 2022, 5:35PM
InvestorPlace - Oct 31, 2022, 7:20PM
Seeking Alpha - Oct 31, 2022, 1:50AM
Seeking Alpha - Oct 30, 2022, 2:30AM
InvestorPlace - Oct 19, 2022, 10:13AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS4.6605.170 0.5100
REV939.060M940.652M1.592M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Thursday, November 10, 2022. The analyst firm set a price target for 192.00 expecting JAZZ to rise to within 12 months (a possible 22.65% upside). 18 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $156.54 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.